Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.74267 | 62 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.69799 | 62 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.68736 | 62 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.63288 | 61 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.65964 | 62 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.81747 | 63 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.84417 | 63 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.68675 | 62 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.67627 | 62 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.68006 | 62 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.68118 | 62 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.68384 | 62 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.69864 | 62 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.6961 | 62 |